LTACHs and MA Plans – Understanding Why The Rules Are Different

LTACHs and MA Plans – Understanding Why The Rules Are Different

In a recent final rule, CMS-4201-F, the Centers for Medicare & Medicaid Services (CMS) went to great lengths to specify that Medicare Advantage (MA) plans must provide MA beneficiaries access to care at inpatient rehabilitation facilities (IRFs), skilled nursing facilities (SNFs), and by home care agencies (HHAs) if the criteria for traditional Medicare access are met. This requirement was codified in 42 § CFR 422.101(b)(2).

Much of this attention by CMS was created by the 2022 report from the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG), which found that a significant percentage of denials of requests for IRF, SNF, and even home care by MA plans would have been permitted under traditional Medicare.

Notably absent from the list of providers for which MA plans must follow the same guidelines as traditional Medicare are long-term acute-care hospitals (LTACHs). A review of the database of denials appealed to the Qualified Independent Contractor (QIC) by the patient or an authorized representative found that from 2020 to the present, 18,266 appeals for denial of access to LTACHs were filed, and only 74, or 0.4 percent of appeals, were ruled in favor of the patient.

While CMS does not give an explanation for not including access to LTACHs in CMS-4201-F, it should be remembered that LTACHs are licensed as acute-care hospitals, differing from short-term acute-care hospitals in that they care for a patient population that consists of patients who have longer lengths of stay and complex medical needs. They provide the same basic services that “regular” acute-care hospitals perform, with medical units, surgical suites, intensive care units, and so on, but are paid differently.

The LTACH payment system from Medicare underwent a change in 2015, with the addition of a site-neutral policy, paying LTACHs at a lower rate, comparable to short-term acute-care hospitals for patients who had not spent at least three days in an intensive care unit or require at least 96 hours of mechanical ventilation. It was thought that this was to deter LTACHs from accepting patients who could be adequately cared for in a SNF, at lower cost to the Medicare Trust Fund.

A study in 2018, looking retrospectively at LTACH admissions in 2012, found that 41 percent of those admissions would have been subjected to a site-neutral adjustment. In 2022, a total of 28 percent of LTACH admissions were paid at the site-neutral rate. This decline reflects what many hospital case managers have anecdotally noted when LTACHs have refused to accept patients who do not meet the criteria for the LTACH payment rate.  

In some instances, patients are transferred to LTACHs for care that could be provided at an acute-care hospital, such as long-term IV medication administration. That transfer may be desired to create capacity for the acute-care facility, especially in the intensive care unit, where resources are often limited. But some have suggested that hospitals seek LTACH transfers because they get paid a fixed DRG for their admission, with perhaps some additional outlier reimbursement, and the shorter they can make the inpatient admission, the more money they make (or lessen their losses).

On the other hand, there are clearly cases for which LTACHs do provide specialized care that is not available at the acute-care facility, such as complex wound care, long-term ventilator weaning, or complex medical management, along with intensive rehabilitation care. In these cases, the transfer to the LTACH should be viewed as no different than a transfer to a tertiary or quaternary care facility, and the discussion with the MA plan should focus on those specialized services – and not on payment.

While the disagreements with MA plans over inpatient admission versus outpatient care with observation services is certain to change in 2024, the ability to transfer patients to LTACHs will remain an obstacle. Understanding the why and how may help guide providers in doing what is best.

Facebook
Twitter
LinkedIn

Ronald Hirsch, MD, FACP, ACPA-C, CHCQM, CHRI

Ronald Hirsch, MD, is vice president of the Regulations and Education Group at R1 Physician Advisory Services. Dr. Hirsch’s career in medicine includes many clinical leadership roles at healthcare organizations ranging from acute-care hospitals and home health agencies to long-term care facilities and group medical practices. In addition to serving as a medical director of case management and medical necessity reviewer throughout his career, Dr. Hirsch has delivered numerous peer lectures on case management best practices and is a published author on the topic. He is a member of the Advisory Board of the American College of Physician Advisors, and the National Association of Healthcare Revenue Integrity, a member of the American Case Management Association, and a Fellow of the American College of Physicians. Dr. Hirsch is a member of the RACmonitor editorial board and is regular panelist on Monitor Mondays. The opinions expressed are those of the author and do not necessarily reflect the views, policies, or opinions of R1 RCM, Inc. or R1 Physician Advisory Services (R1 PAS).

Related Stories

The Enigma of Sepsis

The Enigma of Sepsis

Sepsis is one of the most (if not the most) challenging concepts in the International Classification of Diseases, 10th Edition, Clinical Modification (ICD-10-CM), the Health Insurance Portability and Accountability

Read More

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

2026 IPPS Masterclass 3: Master MS-DRG Shifts and NTAPs

2026 IPPS Masterclass Day 3: MS-DRG Shifts and NTAPs

This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 14, 2025
2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

This second session in our 2026 IPPS Masterclass will feature a review the FY26 changes to ICD-10-PCS codes. This information will be presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 13, 2025
2026 IPPS Masterclass 1: Master ICD-10-CM Changes

2026 IPPS Masterclass Day 1: Master ICD-10-CM Changes

This first session in our 2026 IPPS Masterclass will feature an in-depth explanation of FY26 changes to ICD-10-CM codes and guidelines, CCs/MCCs, and revisions to the MCE, presented by presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 12, 2025

Trending News

Featured Webcasts

The Two-Midnight Rule: New Challenges, Proven Strategies

The Two-Midnight Rule: New Challenges, Proven Strategies

RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.

June 19, 2025
Open Door Forum Webcast Series

Open Door Forum Webcast Series

Bring your questions and join the conversation during this open forum series, live every Wednesday at 10 a.m. EST from June 11–July 30. Hosted by Chuck Buck, these fast-paced 30-minute sessions connect you directly with top healthcare experts tackling today’s most urgent compliance and policy issues.

June 11, 2025
Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Substance abuse is everywhere. It’s a complicated diagnosis with wide-ranging implications well beyond acute care. The face of addiction continues to change so it’s important to remember not just the addict but the spectrum of extended victims and the other social determinants and legal ramifications. Join John K. Hall, MD, JD, MBA, FCLM, FRCPC, for a critical Q&A on navigating substance abuse in 2025.  Register today and be a part of the conversation!

July 16, 2025

Trending News

Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24